Denmark's Stenocare Q4 net sales double

Reuters

Feb 26

Denmark's Stenocare Q4 net sales double

Overview

Denmark medical cannabis supplier's Q4 net sales rose 107% yr/yr
Company achieved positive EBITDA for third consecutive quarter
Company acquired CannGros ApS, adding DKK 4-6 mln in annual revenue

Outlook

Stenocare expects CannGros acquisition to add DKK 4-6 mln in annual revenue
Company aims for break-even in 2026 supported by CannGros acquisition
Stenocare plans to launch Astrum Oil in Germany by Feb 2026

Result Drivers

STRATEGIC INVESTMENTS - Co exited Danish cultivation facility and acquired CannGros ApS, contributing to sales growth and future profitability
COST MANAGEMENT - Co reduced external expenses by 13% and personnel expenses by 37% in Q4 compared to Q4-2024
SALES GROWTH - Q4 sales increased by 36% over Q3-2025 and 107% over Q4-2024

Company press release: ID:nWkr7SP78t

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q4 Sales		DKK 2.61 mln
Q4 EPS		DKK 0
Q4 EBITDA		DKK 12,000

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614092890"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614092890\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614092890?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 15:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614092890","market":"fut","top_or_hot":-1,"title":"Denmark's Stenocare Q4 net sales double","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Denmark's Stenocare Q4 net sales double</title></head><body><p><span>Overview</span></p><ul><li><p>Denmark medical cannabis supplier's Q4 net sales rose 107% yr/yr</p></li><li><p>Company achieved positive EBITDA for third consecutive quarter</p></li><li><p>Company acquired CannGros ApS, adding DKK 4-6 mln in annual revenue</p></li></ul><p><span>Outlook</span></p><ul><li><p>Stenocare expects CannGros acquisition to add DKK 4-6 mln in annual revenue</p></li><li><p>Company aims for break-even in 2026 supported by CannGros acquisition</p></li><li><p>Stenocare plans to launch Astrum Oil in Germany by Feb 2026</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>STRATEGIC INVESTMENTS - Co exited Danish cultivation facility and acquired CannGros ApS, contributing to sales growth and future profitability</p></li><li><p>COST MANAGEMENT - Co reduced external expenses by 13% and personnel expenses by 37% in Q4 compared to Q4-2024</p></li><li><p>SALES GROWTH - Q4 sales increased by 36% over Q3-2025 and 107% over Q4-2024</p></li></ul><p>Company press release: <span>ID:nWkr7SP78t</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>DKK 2.61 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>DKK 0</p></td><td></td></tr><tr><td><p>Q4 EBITDA</p></td><td></td><td><p>DKK 12,000</p></td><td></td></tr></tbody></table><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Denmark's Stenocare Q4 net sales double</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDenmark's Stenocare Q4 net sales double\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-26 15:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Denmark's Stenocare Q4 net sales double</title></head><body><p><span>Overview</span></p><ul><li><p>Denmark medical cannabis supplier's Q4 net sales rose 107% yr/yr</p></li><li><p>Company achieved positive EBITDA for third consecutive quarter</p></li><li><p>Company acquired CannGros ApS, adding DKK 4-6 mln in annual revenue</p></li></ul><p><span>Outlook</span></p><ul><li><p>Stenocare expects CannGros acquisition to add DKK 4-6 mln in annual revenue</p></li><li><p>Company aims for break-even in 2026 supported by CannGros acquisition</p></li><li><p>Stenocare plans to launch Astrum Oil in Germany by Feb 2026</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>STRATEGIC INVESTMENTS - Co exited Danish cultivation facility and acquired CannGros ApS, contributing to sales growth and future profitability</p></li><li><p>COST MANAGEMENT - Co reduced external expenses by 13% and personnel expenses by 37% in Q4 compared to Q4-2024</p></li><li><p>SALES GROWTH - Q4 sales increased by 36% over Q3-2025 and 107% over Q4-2024</p></li></ul><p>Company press release: <span>ID:nWkr7SP78t</span></p><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q4 Sales</p></td><td></td><td><p>DKK 2.61 mln</p></td><td></td></tr><tr><td><p>Q4 EPS</p></td><td></td><td><p>DKK 0</p></td><td></td></tr><tr><td><p>Q4 EBITDA</p></td><td></td><td><p>DKK 12,000</p></td><td></td></tr></tbody></table><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1147","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL1N3ZM09V:1","article_id":"2614092890","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614092890","pubTimestamp":1772089894,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Denmark's Stenocare Q4 net sales doubleOverviewDenmark medical cannabis supplier's Q4 net sales rose 107% yr/yrCompany achieved positive EBITDA for third consecutive quarterCompany acquired CannGros A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1147":"投资银行业与经纪业","08333":"阿仕特朗金融"},"translate_title":"丹麦Stenocare第四季度净销售额翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08333":0.9},"content_text":"Denmark's Stenocare Q4 net sales doubleOverviewDenmark medical cannabis supplier's Q4 net sales rose 107% yr/yrCompany achieved positive EBITDA for third consecutive quarterCompany acquired CannGros ApS, adding DKK 4-6 mln in annual revenueOutlookStenocare expects CannGros acquisition to add DKK 4-6 mln in annual revenueCompany aims for break-even in 2026 supported by CannGros acquisitionStenocare plans to launch Astrum Oil in Germany by Feb 2026Result DriversSTRATEGIC INVESTMENTS - Co exited Danish cultivation facility and acquired CannGros ApS, contributing to sales growth and future profitabilityCOST MANAGEMENT - Co reduced external expenses by 13% and personnel expenses by 37% in Q4 compared to Q4-2024SALES GROWTH - Q4 sales increased by 36% over Q3-2025 and 107% over Q4-2024Company press release: ID:nWkr7SP78tKey DetailsMetricBeat/MissActualConsensus EstimateQ4 SalesDKK 2.61 mlnQ4 EPSDKK 0Q4 EBITDADKK 12,000For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}